BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27857176)

  • 21. Using Drosophila models of Huntington's disease as a translatable tool.
    Lewis EA; Smith GA
    J Neurosci Methods; 2016 May; 265():89-98. PubMed ID: 26241927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of Sleep and Circadian Behavior by Autophagy Modulation in Huntington's Disease.
    Sharma A; Narasimha K; Manjithaya R; Sheeba V
    J Neurosci; 2023 Jun; 43(26):4907-4925. PubMed ID: 37268416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
    Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
    Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained effects of nonallele-specific Huntingtin silencing.
    Drouet V; Perrin V; Hassig R; Dufour N; Auregan G; Alves S; Bonvento G; Brouillet E; Luthi-Carter R; Hantraye P; Déglon N
    Ann Neurol; 2009 Mar; 65(3):276-85. PubMed ID: 19334076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.
    Scappini E; Koh TW; Martin NP; O'Bryan JP
    Hum Mol Genet; 2007 Aug; 16(15):1862-71. PubMed ID: 17550941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.
    Zhu Y; Li C; Tao X; Brazill JM; Park J; Diaz-Perez Z; Zhai RG
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19165-19175. PubMed ID: 31484760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients.
    Pierzynowska K; Gaffke L; Cyske Z; Węgrzyn G
    Metab Brain Dis; 2019 Jun; 34(3):715-720. PubMed ID: 30850940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.
    Li X; Wang CE; Huang S; Xu X; Li XJ; Li H; Li S
    Hum Mol Genet; 2010 Jun; 19(12):2445-55. PubMed ID: 20354076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity.
    Branco-Santos J; Herrera F; Poças GM; Pires-Afonso Y; Giorgini F; Domingos PM; Outeiro TF
    Hum Mol Genet; 2017 Oct; 26(19):3763-3775. PubMed ID: 28934390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.
    Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO
    Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila.
    Poças GM; Branco-Santos J; Herrera F; Outeiro TF; Domingos PM
    Hum Mol Genet; 2015 Apr; 24(7):1898-907. PubMed ID: 25452431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.
    Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS
    J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
    J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.
    Jiang M; Wang J; Fu J; Du L; Jeong H; West T; Xiang L; Peng Q; Hou Z; Cai H; Seredenina T; Arbez N; Zhu S; Sommers K; Qian J; Zhang J; Mori S; Yang XW; Tamashiro KL; Aja S; Moran TH; Luthi-Carter R; Martin B; Maudsley S; Mattson MP; Cichewicz RH; Ross CA; Holtzman DM; Krainc D; Duan W
    Nat Med; 2011 Dec; 18(1):153-8. PubMed ID: 22179319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAG1 modulates huntingtin toxicity, aggregation, degradation, and subcellular distribution.
    Sroka K; Voigt A; Deeg S; Reed JC; Schulz JB; Bähr M; Kermer P
    J Neurochem; 2009 Nov; 111(3):801-7. PubMed ID: 19712056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.
    Brás IC; König A; Outeiro TF
    J Huntingtons Dis; 2019; 8(3):245-256. PubMed ID: 31322580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin.
    Olson SD; Kambal A; Pollock K; Mitchell GM; Stewart H; Kalomoiris S; Cary W; Nacey C; Pepper K; Nolta JA
    Mol Cell Neurosci; 2012 Mar; 49(3):271-81. PubMed ID: 22198539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.